Similar articles

• Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update.

  Walsh PC. Walsh PC. J Urol. 1997 Oct;158(4):1618-9. J Urol. 1997. PMID: 9302186 No abstract available.
• Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.

  Partin AW, Kattan MW, Subong EN, Walsh PC, Wojno KJ, Oesterling JE, Scardino PT, Pearson JD. Partin AW, et al. JAMA. 1997 May 14;277(18):1445-51. JAMA. 1997. PMID: 9145716
• [Prognostic factors of localised, locally advanced or metastatic prostate cancer].

  Joly F, Henry-Amar M. Joly F, et al. Bull Cancer. 2007 Jul;94(7 Suppl):F35-43. Bull Cancer. 2007. PMID: 17845992 Review. French.
• Percentage of cancer in prostate biopsies as prognostic factor for staging and postoperative biochemical failure after radical prostatectomy.

  Villamón-Fort R, Martínez-Jabaloyas JM, Soriano-Sarriá P, Ramos-Soler D, Pastor-Hernández F, Gil-Salom M. Villamón-Fort R, et al. Urol Int. 2007;78(4):328-33. doi: 10.1159/000100837. Urol Int. 2007. PMID: 17495491
• Prostate biopsy: who, how and when. An update.

  Djavan B, Milani S, Remzi M. Djavan B, et al. Can J Urol. 2005 Feb;12 Suppl 1:44-8; discussion 99-100. Can J Urol. 2005. PMID: 15780165 Review.